(Josep Carreras Leukaemia Research Institute) Researchers at the Josep Carreras Leukaemia Research Institute have developed innovative diagnostic trials to identify cells resistant to leukemia treatment. These new trials allow the identification of a subgroup of patients with an unfavorable prognosis at the time of diagnosis of acute myeloid leukemia.
Original source: https://www.eurekalert.org/pub_releases/2020-01/jclr-cti010220.php